Talk:Matthias Hentze/Archive 1

Request edit on 12 June 2015
Dear all,

''As recommended by Jytdog, I'm inserting my editing request here. I've gone through the whole article of Matthias Hentze and added references to the respective sections.''

Please replace all content including section "Editorial Boards" as follows:

Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL) and Professor of Molecular Medicine at Heidelberg University.

Biography
Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton, Oxford, Glasgow and Cambridge, and in Germany at the Westfälische Wilhelms-Universität Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis in the laboratory of Prof. Kurt von Figura. After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council), Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985. In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader. At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg. He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg. Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director. He is also co-founder of Anadys Pharmaceuticals, San Diego, California.

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.

He is married to the German physician Sabine Hentze and has three daughters. He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.

Research
In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA. He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3’end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression.

Honors and Awards (Selection)

 * 2015 — Feodor Lynen Medal and Lecture, German Society for Biochemistry and Molecular Biology
 * 2007 — Lautenschläger Research Prize of the University of Heidelberg
 * 2006 — Elected Member of the "German Academy of Sciences - Leopoldina
 * 2003 — Elected Member of the “European Academy of Sciences”
 * 2000 — Gottfried Wilhelm Leibniz Prize of the "German Research Foundation" (Deutsche Forschungsgemeinschaft)
 * 1997 — Elected member of the "European Molecular Biology Organization" (EMBO)

Editorial Boards

 * Faculty of 1000, Biology and Medicine (since 2010)
 * International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009)
 * Senior Editor, EMBO Molecular Medicine (since 2008)
 * Molecular Cell (since 2004)
 * J. Molecular Medicine (since 2004)
 * BioMed Central Molecular Biology (since 2003)
 * RNA (since 1997)
 * Trends in Biochemical Sciences [TiBS] (since 1996)

The section "Selected Publications" can remain unchanged.

Please add the following to the section "External links" below to what is already there:

Request edit on 21 July 2015
Dear all, In response to the latest comment on my talk page I'm sending another updated request edit. I have again updated the references and also removed unnecessary bits. I'd appreciate a review of the article as well as feedback on my talk page if there are further improvements I need to make before the edit can be implemented. I'd also like to add an infobox and a photograph (copyright holder consent form has been sent on June 26th but we haven't heard back yet - could anyone perhaps help?) but I meant to wait for your feedback on the article first. Many thanks for your help with this. Princessella123 (talk) 13:19, 21 July 2015 (UTC)

Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL) and Professor of Molecular Medicine at Heidelberg University.

Biography
Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton, Oxford, Glasgow and Cambridge, and in Germany at the Westfälische Wilhelms-Universität Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis in the laboratory of Prof. Kurt von Figura.

After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council), Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985. In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader. At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg. He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg. Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director. He is also co-founder of Anadys Pharmaceuticals, San Diego, California.

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.

He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.

Research
In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA. He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3&prime;-end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression.

Honors and Awards (Selection)

 * 2015 — Feodor Lynen Medal and Lecture, German Society for Biochemistry and Molecular Biology
 * 2007 — Lautenschläger Research Prize of the University of Heidelberg
 * 2006 — Elected Member of the "German Academy of Sciences" - Leopoldina
 * 2003 — Elected Member of the "European Academy of Sciences" - EURASC
 * 2000 — Gottfried Wilhelm Leibniz Prize of the "German Research Foundation" (Deutsche Forschungsgemeinschaft)
 * 1997 — Elected member of the European Molecular Biology Organization (EMBO)

Editorial Boards

 * Faculty of 1000, Biology and Medicine (since 2010)
 * International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009)
 * Senior Editor, EMBO Molecular Medicine (since 2008)
 * Molecular Cell (since 2004)
 * J. Molecular Medicine (since 2004)
 * BioMed Central Molecular Biology (since 2003)
 * RNA (since 1997)
 * Trends in Biochemical Sciences [TiBS] (since 1996)

Request edit on 5 August 2015 - Additions to request edit on 21 July
Thanks for your helpful comments! I've now added an infobox and also updated the links of the medical schools (please see below). Yes, in fact these medical schools are part of the respective universities. Could you arrange for the edits to be "approved and implemented"? Thanks a lot for your support. Princessella123 (talk) 13:41, 5 August 2015 (UTC)

Biography
Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton, Oxford, Glasgow and Cambridge, and in Germany at the Westfälische Wilhelms-Universität Münster from which he qualified in 1984.

Request edit on 6 August 2015 (final version)
Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL) and Professor of Molecular Medicine at Heidelberg University.

Biography
Matthias Hentze studied medicine in the UK at the Medical Schools at the University of Southampton, University of Oxford, University of Glasgow and University of Cambridge, and in Germany at the Westfälische Wilhelms-Universität, Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis in the laboratory of Prof. Kurt von Figura.

After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council), Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985. In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader. At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg. He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg. Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director. He is also co-founder of Anadys Pharmaceuticals, San Diego, California.

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.

He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.

Research
In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA. He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3&prime;-end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression. This research project, which focuses on REM Networks was awarded an ERC Advanced Grant of the European Research Council in 2011 and has meanwhile discovered hundreds of new RNA-binding proteins in the stem cells of mammals and yeast, including 50 metabolic enzymes.

Honors and Awards (Selection)

 * 2015 — Feodor Lynen Medal and Lecture, German Society for Biochemistry and Molecular Biology
 * 2007 — Lautenschläger Research Prize of the University of Heidelberg
 * 2006 — Elected Member of the German Academy of Sciences - Leopoldina
 * 2003 — Elected Member of the European Academy of Sciences - EURASC
 * 2000 — Gottfried Wilhelm Leibniz Prize of the German Research Foundation (Deutsche Forschungsgemeinschaft)
 * 1997 — Elected member of the European Molecular Biology Organization (EMBO)

Editorial Boards

 * Faculty of 1000, Biology and Medicine (since 2010)
 * International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009)
 * Senior Editor, EMBO Molecular Medicine (since 2008)
 * Molecular Cell (since 2004)
 * J. Molecular Medicine (since 2004)
 * BioMed Central Molecular Biology (since 2003)
 * RNA (since 1997)
 * Trends in Biochemical Sciences [TiBS] (since 1996)